Polyethylene‐glycol‐modified interleukin‐2 is superior to interleukin‐2 in locoregional immunotherapy of established guinea‐pig tumors von Mattijssen, Vera, Balemans, Lianne T. M., Steerenberg, Peter A., de Mulder, Pieter H. M.

Volltext

PEG-IL-2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclophosphamide von Balemans, L T, Steerenberg, P A, Koppenhagen, F J, Kremer, B H, De Mulder, P H, Claessen, A M, Scheper, R J, Den Otter, W

Volltext

Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activi... von BALEMANS, L. T. M, MATTIJSSEN, V, STEERENBERG, P. A, VAN DRIEL, B. E. M, DE MULDER, P. H. M, DEN OTTER, W

Volltext

Specific tumor memory induced by polyethylene-glycol-modified interleukin-2 requires both helper and cytotoxic T cells von BALEMANS, L. T. M, STEERENBERG, P. A, KREMER, B. H. A, KOPPENHAGEN, F. J, DE MULDER, P. H. M, DEN OTTER, W

Volltext

The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy von Koppenhagen, F J, Balemans, LTM, Steerenberg, P A, Jagmont, T M, Otter, W D, Storm, G

Volltext

Reduction of therapeutic efficacy by a second cycle of PEG-IL-2 von STEERENBERG, P. A, BALEMANS, L. T. M, KREMER, B. H. A, KOPPENHAGEN, F. J, DE MULDER, P. H. M, DEN OTTER, W

Volltext